Literature DB >> 8857932

Cellular and molecular mechanisms in chronic myeloid leukaemia: biology and treatment.

M Y Gordon1, J M Goldman.   

Abstract

Entities:  

Mesh:

Year:  1996        PMID: 8857932

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  5 in total

Review 1.  Biological consequences of the BCR/ABL fusion gene in humans and mice.

Authors:  M Y Gordon
Journal:  J Clin Pathol       Date:  1999-10       Impact factor: 3.411

Review 2.  Treatment of chronic myelogenous leukaemia.

Authors:  B Simonsson
Journal:  Med Oncol       Date:  1998-04       Impact factor: 3.064

3.  Molecular detection of c-mpl thrombopoietin receptor gene expression in chronic myeloproliferative disorders.

Authors:  S Duensing; A Duensing; J G Meran; A Kreft; G Büsche; A Ganser; A Georgii
Journal:  Mol Pathol       Date:  1999-06

4.  Treatment with interferon-alpha preferentially reduces the capacity for amplification of granulocyte-macrophage progenitors (CFU-GM) from patients with chronic myeloid leukemia but spares normal CFU-GM.

Authors:  M Y Gordon; S B Marley; J L Lewis; R J Davidson; D X Nguyen; F H Grand; T A Amos; J M Goldman
Journal:  J Clin Invest       Date:  1998-08-15       Impact factor: 14.808

5.  A stochastic model of oncogene expression and the relevance of this model to cancer therapy.

Authors:  Francis D Alfano
Journal:  Theor Biol Med Model       Date:  2006-01-31       Impact factor: 2.432

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.